8-K
Advanced Drainage Systems, Inc. (WMS)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 2, 2022
ADVANCED DRAINAGE SYSTEMS, INC.
(Exact name of Registrant as Specified in Its Charter)
| Delaware | 001-36557 | 51-0105665 | |
|---|---|---|---|
| (State or Other Jurisdiction<br><br>of Incorporation) | (Commission File Number) | (IRS Employer<br><br>Identification No.) | |
| 4640 Trueman Boulevard, | 43026 | ||
| Hilliard, | Ohio | ||
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s Telephone Number, Including Area Code: (614) 658-0050
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading<br><br>Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common Stock, $0.01 par value per share | WMS | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events
On February 2, 2022, the Board of Directors (the "Board") of Advanced Drainage Systems, Inc. (the "Company") authorized a cash contribution to the Advanced Drainage Systems, Inc. Employee Stock Ownership Plan (the "ESOP"). The ESOP operates as a tax-qualified leveraged ESOP and was designed to enable eligible employees to acquire stock ownership interests in their ESOP accounts. The ESOP was originally funded with a 30-year term loan from the Company (the "ESOP Loan"), together with a transfer of funds from the Company’s existing profit sharing retirement plan, which were then used by the ESOP to purchase shares of the Company’s 2.5% cumulative convertible preferred stock (the "Preferred Stock"). The ESOP Loan is secured by a pledge of shares of Preferred Stock that have not yet been released from the pledge and allocated to ESOP accounts. Within 30 days following the repayment of the ESOP Loan, the ESOP committee can direct the shares of Preferred Stock owned by the ESOP to be converted into shares of the Company’s common stock ("Common Stock"). The amount of the cash contribution authorized by the Board is an amount that is sufficient to pay off the ESOP Loan, which has a current outstanding balance of approximately $0.3 million. The terms of the ESOP are further described in the Company’s periodic reports as filed with the Securities and Exchange Commission ("SEC").
On February 3, 2022, the ESOP committee notified the Company that it will instruct the ESOP trustee to repay the remaining balance of the ESOP Loan in full with the proceeds from the cash contribution, effective as of March 31, 2022, and that following the repayment of the ESOP Loan, the ESOP trustee will cause the remaining 0.3 million shares of Preferred Stock to be released from the pledge, and all currently outstanding shares of Preferred Stock held by the ESOP will thereafter be converted into shares of the Company’s Common Stock at the conversion rate, with such conversion to be effective within thirty days following the ESOP Loan repayment (the "Preferred Stock Conversion"). The repayment of the ESOP Loan, release of shares of Preferred Stock from the pledge securing the ESOP Loan, allocation of shares of Preferred Stock to ESOP participants’ accounts and the Preferred Stock Conversion are collectively referred to as the "ESOP Transition Events". The Board has further authorized the merger of the ESOP into the Company’s existing 401(k) retirement plan, to become effective as of April 1, 2022, immediately following the completion of the ESOP Transition Events.
Item 9.01 Financial Statements and Exhibits.
The Company is filing with this Current Report on Form 8-K certain unaudited pro forma financial information of the Company to give effect to the ESOP Transition Events, as further described below. The information included in Exhibit 99.1, which is attached hereto and incorporated by reference, is being provided on a voluntary basis to illustrate the pro forma effect of the ESOP Transition Events on the Company’s historical financial statements, and is being provided in conformity with Article 11 of Regulation S-X.
(b) Pro forma financial information.
Unaudited pro forma financial information of the Company for the fiscal year ended March 31, 2021 and for the nine months ended December 31, 2021, giving effect to the ESOP Transition Events, are attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.
(d)Exhibits
The following exhibits are being furnished as part of this report:
| 99.1 | Unaudited pro forma combined financial information of the Company for the fiscal year ended March 31, 2021 and for the nine months ended December 31, 2021. |
|---|---|
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Disclosures About Forward-Looking Statements
Certain statements in this Current Report on Form 8-K may be deemed to be forward-looking looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.
Such statements include, but are not limited to, statements regarding the anticipated ESOP Transition Events and the expected impact on the Company’s financial statements and other financial data, the anticipated timing for the completion of the ESOP Transition Events and other matters related to the ESOP. These statements are not historical facts but rather are based on the Company’s current expectations, estimates and projections regarding the Company’s business, operations and other factors relating thereto. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates" and similar expressions are used to identify these forward-looking statements. Factors that could cause actual results to differ from those reflected in forward-looking statements include, but are not limited to, uncertainties described in the Company’s filings with the SEC. New risks and uncertainties emerge from time to time and it is not possible for the Company to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Current Report on Form 8-K. In light of the significant risks and uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by the Company or any other person that the Company’s expectations, objectives or plans will be achieved in the timeframe anticipated or at all. Investors are cautioned not to place undue reliance on the Company’s forward-looking statements and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ADVANCED DRAINAGE SYSTEMS, INC. | ||
|---|---|---|
| Date: February 3, 2022 | By: | /s/ Scott A. Cottrill |
| Name: | Scott A. Cottrill | |
| Title: | EVP, CFO & Secretary |
Document
Exhibit 99.1
UNAUDITED PRO FORMA FINANCIAL INFORMATION
(Dollar amounts presented in thousands, except per share amounts)
Advanced Drainage Systems, Inc. (the "Company" or "ADS") established an Employee Stock Ownership Plan (the "ESOP" or the "Plan") effective April 1, 1993. The Plan operates as a tax-qualified leveraged ESOP and was designed to enable eligible employees to acquire stock ownership interests in ADS. The Plan was originally funded through a transfer of assets from the Company’s tax-qualified profit-sharing retirement plan, as well as a 30-year term loan from ADS ("the ESOP Loan").
The Plan assets include all issued and outstanding shares of the Company's 2.5% cumulative convertible preferred stock, $0.01 par value per share (the "Preferred Stock"). The ESOP Loan is secured by a pledge of unallocated Preferred Stock that has not yet been released from the ESOP Loan pledge and allocated to ESOP participants' accounts. The Preferred Stock is convertible into shares of the Company's common stock, $0.01 par value per share ("Common Stock") and has a required cumulative 2.5% dividend (based on the liquidation value of $0.7818 per share) and is currently convertible at a rate of 0.7692 shares of Common Stock for each share of Preferred Stock (the "Conversion Rate"). The 2.5% annual dividend is payable in cash or additional shares of Preferred Stock.
Within 30 days following the repayment of the ESOP loan, the ESOP committee can direct the shares of Preferred Stock owned by the ESOP to be converted into shares of the Company’s Common Stock. On February 3, 2022, the ESOP committee notified the Company that it will instruct the ESOP trustee to cause the repayment of the remaining balance of the ESOP Loan in full with proceeds from a cash contribution to be paid by the Company to the ESOP, which repayment will be effective as of March 31, 2022, and that following the repayment of the ESOP Loan, the ESOP trustee will cause the remaining 0.3 million shares of Preferred Stock to be released from the pledge, and all currently outstanding shares of Preferred Stock held by the ESOP will thereafter be converted into shares of the Company’s Common Stock at the Conversion Rate, with such conversion to be effective within 30 days following the ESOP Loan repayment(the "Preferred Stock Conversion").
The following unaudited pro forma financial information of the Company, including the explanatory notes (collectively, the "pro forma financial information") are presented to illustrate the effects of (i) the repayment of the ESOP loan by the ESOP, (ii) the allocation of the remaining unallocated shares of Preferred Stock released from the pledge securing the ESOP Loan, (iii) and the completion of the Preferred Stock Conversion (collectively, the "ESOP Transition Events").
In addition to the ESOP Transition Events, the pro forma financial information reflects an estimated annual compensation expense ("401k Expense") for the retirement plan that replaces the ESOP.
The pro forma financial information was based on, and should be read in conjunction with, the following historical consolidated financial information and accompanying notes:
–Audited historical consolidated financial statements of the Company, and the related notes for the fiscal year ended March 31, 2021, included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021; and
–Unaudited historical condensed consolidated financial statements of the Company, and the related notes for the nine months ended December 31, 2021, included in the Company’s Quarterly Report on Form 10-Q for the three and nine months ended ended December 31, 2021.
The unaudited pro forma balance sheet as of December 31, 2021 assumes the ESOP Transition Events occurred on December 31, 2021. The unaudited pro forma statements of operations for the year ended March 31, 2021 and for the nine months ended December 31, 2021, assumes the ESOP Transition Events occurred on April 1, 2020, the beginning of the Company’s fiscal year ended March 31, 2021.
In the opinion of management, all adjustments necessary to present fairly the pro forma financial information have been reflected. The assumptions underlying the pro forma adjustments are described fully in the accompanying notes, which should be read in conjunction with the pro forma financial information. The pro forma financial information are unaudited and are not necessarily indicative of the financial position or results of operations that would have been realized had the ESOP Transition Events occurred as of the dates indicated, nor is it meant to be indicative of any anticipated financial position or future results of operations that the Company will experience after the ESOP Transition Events.
Financial Statements
UNAUDITED PRO FORMA CONDENSED BALANCE SHEET
AS OF DECEMBER 31, 2021
(in thousands)
| Historical | ESOP Transition Events | Ref | Pro Forma | ||||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current assets: | |||||||
| Cash | $ | 22,173 | $ | — | $ | 22,173 | |
| Receivables | 303,140 | — | 303,140 | ||||
| Inventories | 465,518 | — | 465,518 | ||||
| Other current assets | 16,188 | — | 16,188 | ||||
| Total current assets | 807,019 | — | 807,019 | ||||
| Property, plant and equipment, net | 590,949 | — | 590,949 | ||||
| Other assets: | |||||||
| Goodwill | 611,578 | — | 611,578 | ||||
| Intangible assets, net | 447,411 | — | 447,411 | ||||
| Other assets | 98,802 | — | 98,802 | ||||
| Total assets | $ | 2,555,759 | $ | — | $ | 2,555,759 | |
| LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY | |||||||
| Current liabilities: | |||||||
| Current maturities of debt obligations | $ | 20,764 | $ | — | $ | 20,764 | |
| Current maturities of finance lease obligations | 5,167 | — | 5,167 | ||||
| Accounts payable | 195,471 | — | 195,471 | ||||
| Other accrued liabilities | 140,578 | — | 140,578 | ||||
| Accrued income taxes | 2,104 | — | 2,104 | ||||
| Total current liabilities | 364,084 | — | 364,084 | ||||
| Long-term debt obligations | 931,765 | — | 931,765 | ||||
| Long-term finance lease obligations | 13,354 | — | 13,354 | ||||
| Deferred tax liabilities | 172,143 | — | 172,143 | ||||
| Other liabilities | 53,903 | — | 53,903 | ||||
| Total liabilities | 1,535,249 | — | 1,535,249 | ||||
| Mezzanine equity: | |||||||
| Redeemable convertible preferred stock: $0.01 par value; 47,070 shares authorized;<br>44,170 shares issued; 16,871 shares outstanding, respectively | 210,888 | (210,888) | 2b | — | |||
| Redeemable common stock, 12,977 shares outstanding | — | 210,888 | 2b | 210,888 | |||
| Deferred compensation – unearned ESOP shares | (5,146) | 5,146 | 2a | — | |||
| Total mezzanine equity | 205,742 | 5,146 | 210,888 | ||||
| Stockholders’ equity: | |||||||
| Common stock; $0.01 par value: 1,000,000 shares authorized; 74,492<br> shares issued, respectively; 71,295 shares outstanding, respectively | 11,601 | — | 11,601 | ||||
| Paid-in capital | 1,008,610 | 46,686 | 2a | 1,055,296 | |||
| Common stock in treasury, at cost | (316,049) | — | (316,049) | ||||
| Accumulated other comprehensive loss | (26,681) | — | (26,681) | ||||
| Retained earnings | 121,918 | (51,832) | 2a | 70,086 | |||
| Total ADS stockholders’ equity | 799,399 | (5,146) | 794,253 | ||||
| Noncontrolling interest in subsidiaries | 15,369 | — | 15,369 | ||||
| Total stockholders’ equity | 814,768 | (5,146) | 809,622 | ||||
| Total liabilities, mezzanine equity and stockholders’ equity | $ | 2,555,759 | $ | — | $ | 2,555,759 |
UNAUDITED PRO FORMA CONDENSED STATEMENT OF OPERATIONS
FOR THE NINE MONTHS ENDED DECEMBER 31, 2021
(in thousands, except per share data)
| Historical | ESOP Transition Events | Ref | 401k Expense | Ref | Pro Forma | Ref | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | $ | 2,091,128 | $ | — | $ | — | $ | 2,091,128 | |||
| Cost of goods sold | 1,480,973 | (27,657) | 3a | 4,297 | 4a | 1,457,613 | |||||
| Gross profit | 610,155 | 27,657 | (4,297) | 633,515 | |||||||
| Operating expenses: | |||||||||||
| Selling, general and administrative | 230,231 | (15,732) | 3a | 2,453 | 4a | 216,952 | |||||
| Loss on disposal of assets and costs from exit and disposal activities | 2,554 | — | — | 2,554 | |||||||
| Intangible amortization | 46,229 | — | — | 46,229 | |||||||
| Income from operations | 331,141 | 43,389 | (6,750) | 367,780 | |||||||
| Other expense: | |||||||||||
| Interest expense | 25,100 | — | — | 25,100 | |||||||
| Derivative gains and other income, net | (2,791) | — | — | (2,791) | |||||||
| Income before income taxes | 308,832 | 43,389 | (6,750) | 345,471 | |||||||
| Income tax expense | 82,063 | 1,216 | 3b | (1,755) | 4b | 81,524 | |||||
| Equity in net (income) loss of unconsolidated affiliates | (1,128) | — | — | (1,128) | |||||||
| Net income | 227,897 | 42,173 | (4,995) | 265,075 | |||||||
| Less: net income attributable to noncontrolling interest | 2,873 | — | — | 2,873 | |||||||
| Net income attributable to ADS | 225,024 | 42,173 | (4,995) | 262,202 | |||||||
| Weighted average common shares outstanding: | |||||||||||
| Basic | 71,087 | 13,952 | 5 | 85,039 | |||||||
| Diluted | 72,752 | 13,952 | 5 | 86,704 | |||||||
| Net income per share: | |||||||||||
| Basic | $ | 2.67 | $ | 3.08 | 5 | ||||||
| Diluted | $ | 2.61 | $ | 3.02 | 5 |
UNAUDITED PRO FORMA STATEMENT OF OPERATIONS
FOR THE FISCAL YEAR ENDED MARCH 31, 2021
(in thousands, except per share data)
| Historical | ESOP Transition Events | Ref | 401k Expense | Ref | Pro Forma | Ref | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | $ | 1,982,780 | $ | — | $ | — | $ | 1,982,780 | |||
| Cost of goods sold | 1,292,698 | (29,861) | 3a | 5,729 | 4a | 1,268,566 | |||||
| Gross profit | 690,082 | 29,861 | (5,729) | 714,214 | |||||||
| Operating expenses: | — | ||||||||||
| Selling, general and administrative | 267,574 | (15,120) | 3a | 3,271 | 4a | 255,725 | |||||
| Loss on disposal of assets and costs from exit and disposal activities | 4,275 | — | — | 4,275 | |||||||
| Intangible amortization | 73,708 | — | — | 73,708 | |||||||
| Income (loss) from operations | 344,525 | 44,981 | (9,000) | 380,506 | |||||||
| Other expense: | — | ||||||||||
| Interest expense | 35,658 | — | — | 35,658 | |||||||
| Derivative (gains) losses and other (income) expense, net | (3,404) | — | — | (3,404) | |||||||
| Income (loss) before income taxes | 312,271 | 44,981 | (9,000) | 348,252 | |||||||
| Income tax expense | 86,382 | 1,394 | 3b | (2,340) | 4b | 85,436 | |||||
| Equity in net (income) loss of unconsolidated affiliates | (201) | — | — | (201) | |||||||
| Net income (loss) | 226,090 | 43,587 | (6,660) | 263,017 | |||||||
| Less: net income attributable to noncontrolling interest | 1,860 | — | — | 1,860 | |||||||
| Net income (loss) attributable to ADS | 224,230 | 43,587 | (6,660) | 261,157 | |||||||
| Weighted average common shares outstanding: | |||||||||||
| Basic | 70,155 | 16,001 | 5 | 86,156 | |||||||
| Diluted | 71,566 | 16,001 | 5 | 87,567 | |||||||
| Net income (loss) per share available to common stockholders: | |||||||||||
| Basic | $ | 2.64 | $ | 3.03 | 5 | ||||||
| Diluted | $ | 2.59 | $ | 2.98 | 5 |
ADVANCED DRAINAGE SYSTEMS, INC.
NOTES TO THE UNAUDITED CONDENSED PRO FORMA FINANCIAL INFORMATION
1.BASIS OF PRESENTATION
The unaudited pro forma financial information and related notes were prepared in accordance with Article 11 of Regulation S-X and is based upon ADS’s fiscal year end reporting, which ends on March 31 of each calendar year.
2.UNAUDITED PRO FORMA CONDENSED BALANCE SHEET ADJUSTMENTS
(a) The approximately 0.5 million remaining unallocated shares of Preferred Stock are assumed to be allocated assuming a fair value of $104.71, which is the common stock price of $136.13 as of December 31, 2021 at the conversion rate of 0.7692. An adjustment to compensation expense related to the allocation is recorded to retained earnings at fair value and the remaining balance of deferred compensation is reduced to zero. Any difference between deferred compensation and the fair value of the shares allocated is recorded as paid-in capital.
(b) After the repayment of the ESOP loan, the remaining unallocated shares of Preferred Stock will be allocated, and within thirty days following ESOP Loan repayment all outstanding shares of Preferred Stock will convert to Common Stock at the rate of 0.7692 shares of Common Stock for each share of Preferred Stock, which are classified in the unaudited pro forma balance sheet and referred to as "Redeemable common stock". These adjustments reflect the adjustment of the conversion of the Preferred Stock to Redeemable common stock reflecting the existing carrying value.
3.UNAUDITED PRO FORMA STATEMENT OF OPERATIONS ADJUSTMENT RELATED TO ESOP TRANSITION EVENTS
(a) These adjustments reflect the reduction to ESOP compensation expense recorded to eliminate the expense recorded during the periods presented, as the ESOP compensation expense will no longer be incurred after the Preferred Stock is fully allocated as part of the ESOP Transition Events.
| (in thousands) | Nine Months Ended December 31, 2021 | Fiscal Year Ended March 31, 2021 | ||
|---|---|---|---|---|
| Cost of goods sold | $ | 27,657 | $ | 29,861 |
| Selling, general & administrative expenses | 15,732 | 15,120 | ||
| ESOP compensation expense | $ | 43,389 | $ | 44,981 |
The ESOP Transition Events will result in accelerated ESOP compensation expense that is not reflected in the pro forma financial information. The accelerated ESOP compensation expense is based on the number of the Preferred Stock allocated and is estimated to be $34 million using the common stock price at December 31, 2021 adjusted for the conversion rate of 0.7692. The accelerated ESOP compensation expense will be recorded in the fourth quarter of fiscal 2022 and has no effect on the pro forma financial information.
(b) The income tax deduction for expense is limited to the Company’s original basis in the Preferred Stock. ADS elected to use the actual tax effect rather than the pro forma rate due to the deduction limitation as it is more representative of the impact.
4.UNAUDITED PRO FORMA STATEMENT OF OPERATIONS ADJUSTMENT RELATED TO 401K EXPENSE
(a) ADS expects to execute replacement retirement plans, including the merger of its ESOP into its 401(k) retirement plan to form a combined 401(k) plan and ESOP ("KSOP") with employer matching contributions, which will result in incremental annual compensation expense of approximately $8 million to $10 million, which the mid-point of is reflected in the pro forma financial information.
| (in thousands) | Nine Months Ended December 31, 2021 | Fiscal Year Ended March 31, 2021 | ||
|---|---|---|---|---|
| Cost of goods sold | $ | 4,297 | $ | 5,729 |
| Selling, general & administrative expenses | 2,453 | 3,271 | ||
| ESOP compensation expense | $ | 6,750 | $ | 9,000 |
(b) Reflects the income tax effect of the pro forma adjustments using an estimated state and federal statutory tax rate of 26%
5.UNAUDITED NET INCOME PER SHARE
Basic net income per share is calculated by dividing the Net income available to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents. Diluted net income per share is computed by dividing the Net income available to common stockholders by the weighted-average number of common stock equivalents outstanding for the period.
Holders of redeemable convertible preferred stock participate in dividends on an as-converted basis when declared on common stock. Preferred Stock meets the definition of participating securities, which requires the Company to apply the two-class method to compute both basic and diluted net income per share. The two-class method is an earnings allocation formula that treats participating securities as having rights to earnings that would otherwise have been available to common stockholders. The dilutive effect of stock options, redeemable common stock, performance units and unvested nonparticipating restricted stock is based on the more dilutive of the treasury stock method or the diluted two-class method.
The following reflects the adjustments to both basic and diluted net income per share for (1) the changes to net income attributable to ADS noted in the unaudited pro forma statements of operations, (2) the conversion of the Preferred Stock to Redeemable common stock and (3) the adjustment to the methodology of calculating net income per share from using the two-class method to the treasury stock method, as all holders will be common stock holders and no longer participating shareholders.
| Nine Months Ended December 31, 2021 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (In thousands, except per share data) | Historical | ESOP Transition Events | 401k Expense | Proforma | ||||||
| NET INCOME PER SHARE—BASIC: | ||||||||||
| Net income attributable to ADS | $ | 225,024 | $ | 42,173 | (a) | $ | (4,995) | (d) | $ | 262,202 |
| Adjustments for: | ||||||||||
| Dividends to participating securities | (4,633) | 4,633 | (b) | — | — | |||||
| Net income available to common stockholders and participating securities | 220,391 | 46,806 | (4,995) | 262,202 | ||||||
| Undistributed income allocated to participating securities | (30,870) | 30,870 | (b) | — | — | |||||
| Net income available to common stockholders – Basic | 189,521 | 77,676 | (4,995) | 262,202 | ||||||
| Weighted average number of common shares outstanding – Basic | 71,087 | 13,952 | (c) | — | 85,039 | |||||
| Net income per common share – Basic | $ | 2.67 | $ | 3.08 | ||||||
| NET INCOME PER SHARE—DILUTED: | ||||||||||
| Net income available to common stockholders – Diluted | 189,521 | 77,676 | (4,995) | 262,202 | ||||||
| Weighted average number of common shares outstanding – Basic | 71,087 | — | — | 85,039 | ||||||
| Assumed restricted stock - nonparticipating | 245 | — | — | 245 | ||||||
| Assumed exercise of stock options | 904 | — | — | 904 | ||||||
| Assumed performance units | 516 | — | — | 516 | ||||||
| Weighted average number of common shares outstanding – Diluted | 72,752 | 13,952 | (c) | — | 86,704 | |||||
| Net income per common share – Diluted | $ | 2.61 | $ | 3.02 | ||||||
| Fiscal Year Ended March 31, 2021 | ||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (In thousands, except per share data) | Historical | ESOP Transition Events | 401k Expense | Proforma | ||||||
| NET INCOME PER SHARE—BASIC: | ||||||||||
| Net income attributable to ADS | $ | 224,230 | $ | 43,587 | (a) | $ | (6,660) | (d) | $ | 261,157 |
| Adjustments for: | ||||||||||
| Dividends to participating securities | (5,591) | 5,591 | (b) | — | — | |||||
| Net income available to common stockholders and participating securities | 218,639 | 49,178 | (6,660) | 261,157 | ||||||
| Undistributed income allocated to participating securities | (33,251) | 33,251 | (b) | — | — | |||||
| Net income available to common stockholders – Basic | 185,388 | 82,429 | (6,660) | 261,157 | ||||||
| Weighted average number of common shares outstanding – Basic | 70,155 | 16,001 | (c) | — | 86,156 | |||||
| Net income per common share – Basic | $ | 2.64 | $ | 3.03 | ||||||
| NET INCOME PER SHARE—DILUTED: | ||||||||||
| Net income available to common stockholders – Diluted | 185,388 | 82,429 | (6,660) | 261,157 | ||||||
| Weighted average number of common shares outstanding – Basic | 70,155 | — | — | 86,156 | ||||||
| Assumed restricted stock - nonparticipating | 247 | — | — | 247 | ||||||
| Assumed exercise of stock options | 844 | — | — | 844 | ||||||
| Assumed performance units | 320 | — | — | 320 | ||||||
| Weighted average number of common shares outstanding – Diluted | 71,566 | 16,001 | (c) | — | 87,567 | |||||
| Net income per common share – Diluted | $ | 2.59 | $ | 2.98 |
(a) Reflects the adjustment for the changes to Net income attributable to ADS related to the ESOP Transition Events outlined in the Pro Forma Statement of Operations
(b) Reflects the elimination of adjustments for participating securities as the Company is no longer required to calculate earnings per share using the two-class method, which allocates earnings to participating securities
(c) Reflects the conversion of Preferred Stock to redeemable common shares
(d) Reflects the the adjustment for the changes to Net income attributable to ADS related to the 401k expense outlined in the Pro Forma Statement of Operations
-
SUPPLEMENTAL NON-GAAP FINANCIAL MEASURES
Adjusted EBITDA and Adjusted EBITDA Margin - Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures, have been included with pro forma financial information as supplemental measures of financial performance that are not required by, or presented in accordance with GAAP and should not be considered as alternatives to net income as measures of financial performance or cash flows from operations or any other performance measure derived in accordance with GAAP. We calculate Adjusted EBITDA as net income (loss) before interest, income taxes, depreciation and amortization, stock-based compensation expense, non-cash charges and certain other expenses. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by net sales.
Adjusted EBITDA and Adjusted EBITDA Margin are key metrics used by management and our board of directors to assess our consolidated financial performance. These non-GAAP financial measures are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. In addition to covenant compliance and executive performance evaluations, we use these non-GAAP financial measures to supplement GAAP measures of performance to evaluate the effectiveness of our consolidated business strategies, to make budgeting decisions and to compare our performance against that of other peer companies using similar measures. We use Adjusted EBITDA Margin to evaluate our ability to generate profitable sales.
Adjusted EBITDA and Adjusted EBITDA Margin contain certain other limitations, including the failure to reflect our cash expenditures, cash requirements for working capital needs, cash expenditures to replace assets being depreciated and
amortized and interest expense, or the cash requirements necessary to service interest on principal payments on our indebtedness. In evaluating Adjusted EBITDA and Adjusted EBITDA Margin, you should be aware that in the future we will incur expenses that are the same as or similar to some of the adjustments in this presentation, such as stock-based compensation expense, derivative fair value adjustments, and foreign currency transaction losses. Management compensates for these limitations by relying on our GAAP results and using non-GAAP measures on a supplemental basis.
The following tables present a reconciliation of Adjusted EBITDA to Net income, the most comparable GAAP measure, for the periods presented (amounts in thousands):
| Nine Months Ended December 31, 2021 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Historical | ESOP Transition Events | 401k Expense | Pro Forma | |||||||
| Net income | $ | 227,897 | $ | 42,173 | $ | (4,995) | $ | 265,075 | ||
| Depreciation and amortization | 103,687 | — | — | 103,687 | ||||||
| Interest expense | 25,100 | — | — | 25,100 | ||||||
| Income tax expense | 82,063 | 1,216 | (1,755) | 81,524 | ||||||
| EBITDA | 438,747 | 43,389 | (6,750) | 475,386 | ||||||
| Loss on disposal of assets and costs from exit and disposal activities | 2,554 | — | — | 2,554 | ||||||
| ESOP and stock-based compensation expense | 61,900 | (43,389) | — | 18,511 | ||||||
| Transaction costs | 3,022 | — | — | 3,022 | ||||||
| Other adjustments | 1,318 | — | — | 1,318 | ||||||
| Adjusted EBITDA | $ | 507,541 | $ | — | $ | (6,750) | $ | 500,791 | ||
| Adjusted EBITDA Margin | 24.3 | % | 23.9 | % | ||||||
| Fiscal Year Ended March 31, 2021 | ||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Historical | ESOP Transition Events | 401k Expense | Pro Forma | |||||||
| Net income | $ | 226,090 | $ | 43,587 | $ | (6,660) | $ | 263,017 | ||
| Depreciation and amortization | 145,586 | — | — | 145,586 | ||||||
| Interest expense | 35,658 | — | — | 35,658 | ||||||
| Income tax expense | 86,382 | 1,394 | (2,340) | 85,436 | ||||||
| EBITDA | 493,716 | 44,981 | (9,000) | 529,697 | ||||||
| Loss on disposal of assets and costs from exit and disposal activities | 4,275 | — | — | 4,275 | ||||||
| ESOP and stock-based compensation expense | 65,434 | (44,981) | — | 20,453 | ||||||
| Transaction costs | 1,415 | — | — | 1,415 | ||||||
| Strategic growth and operational improvement initiatives | 3,304 | — | — | 3,304 | ||||||
| COVID-19 related expenses | 806 | — | — | 806 | ||||||
| Other adjustments | (1,995) | — | — | (1,995) | ||||||
| Adjusted EBITDA | $ | 566,955 | $ | — | $ | (9,000) | $ | 557,955 | ||
| Adjusted EBITDA Margin | 28.6 | % | 28.1 | % |
8